However, transplantation studies have shown that LSCs are also present in at least one other subpopulation, usually the CD34+CD38+ fraction or sometimes the CD34− fraction, as shown in half of AML cases with mutated nucleophosmin-1 (NPM1), a molecular lesion usually associated with low CD34 expression [43]. Here, CD34 is linked to acute myeloid leukemia.